By Tom Emerick
First Posted at Cracking Health Costs on 3/13/2013
According to an article by Alicia Caramenico in FierceHealthcare, a study shows that higher charges for cancer care do not result in better outcomes. Imagine that.
According to the article, “Medicare spending for advanced cancer significantly varies across regions, but there is no direct link between higher regional spending and improved patient survival, according to a study published yesterday in the Journal of the National Cancer Institute.”
Further, “Advanced cancer spending varied by up to 41 percent between high- and low-spending regions.” No appreciable differences in outcomes were seen.
To regular readers of Cracking Health Costs, this kind of thing is old hat. The problem is that no one is doing anything about that 41% variation in charges. Inasmuch as the government cannot deal with these kinds of problems for political reasons, then by default if corporations won’t take this mess on, who will?